Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

Share Price is delayed by 15 minutes
Get Live Data
8.65    0.00 (0.00%)
Bid:
8.30
Ask:
9.00
Spread: 0.70 (8.434%)
Market Cap: £18.86m
IXI Live PriceLast checked at - London Stock Exchange

Intraday Ixico Share Chart

Director/PDMR Shareholding

9 Jul 2008 16:40

RNS Number : 7217Y
Phytopharm PLC
09 July 2008
 

Phytopharm plc

9 July 2008

DIRECTOR/PDMR SHAREHOLDING - Purchase of Ordinary Shares (the "Shares") in Phytopharm plc (the "Company") by Directors of the Company under its employee Share Incentive Plan (the "SIP").

The SIP trustee, Equiniti Share Plan Trustees Limited (the "Trustee"), notified the Company on 8 July 2008 that the following Directors of the Company acquired Shares under the SIP on 7 July 2008, in each case, held by the Trustee:

Director

Number of shares acquired*

Aggregate number of Shares held beneficially following acquisition (across all accounts)

Daryl Rees

1,164

128,763

Piers Morgan

1,164

128,763

\* The number of Shares acquired includes 582 Partnership Shares purchased by each of these Directors at 21.5 pence and 582 Matching Shares issued to each of these Directors. Both partnership and matching elements are registered in the name of the Trustee.

The SIP operates as follows:

Each month the Trustee uses participants' contributions (which may not exceed £125 per participant per month) to purchase shares in the market. These shares are called "Partnership Shares".

At the same time the Company issues to participants via the Trustee one "Matching Share" for every Partnership Share purchased that month. These Matching Shares are purchased in the market and will vest with the employee three years from the date of purchase.

For further information, please contact:

Zoe McGowan, Company Secretary

Phytopharm plc Tel No: +44 (0)1480 437697

Further information about Phytopharm can be found on the Company's website www.phytopharm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSRLMATMMBMBFP
Date   Source Headline
16th Dec 20247:00 amRNS-RCommercial agreement with PETNET Solutions Inc
10th Dec 20247:00 amRNSContract Win
4th Dec 202411:35 amRNSShare Option Award & PDMR Dealings
4th Dec 20247:00 amRNSFinancial Results for year ended 30 September 2024
25th Nov 20247:00 amRNSNotice of Results and Investor Presentation
31st Oct 20247:00 amRNSShare Option Awards & PDMR Dealing
30th Oct 20244:50 pmRNSHolding(s) in Company
29th Oct 20244:00 pmRNSHolding(s) in Company
29th Oct 202410:58 amRNSHolding(s) in Company
28th Oct 20244:59 pmRNSHolding(s) in Company
28th Oct 202411:00 amRNSDirector/PDMR Shareholdings
25th Oct 202412:55 pmRNSResult of GM, Issue of Equity & TVR
22nd Oct 20243:00 pmRNSCorrection of clerical error
17th Oct 20247:00 amRNSHolding(s) in Company
16th Oct 20247:00 amRNSDirector/PDMR Shareholding
15th Oct 20247:00 amRNSResult of Retail Offer
10th Oct 20241:30 pmRNSExercise of Options & Director/PDMR Purchase
9th Oct 20247:00 amRNSResult of Placing and Subscription
8th Oct 20244:40 pmRNSRetail Offer
8th Oct 20244:35 pmRNSPlacing and Subscription
14th Aug 20247:01 amRNSTrading Update
14th Aug 20247:00 amRNSContract Win
5th Aug 20247:00 amRNSBoard Appointment
29th Jul 20247:00 amRNSFurther progress in HD consortium
20th Jun 20245:45 pmRNSHolding(s) in Company
19th Jun 20247:00 amRNSContract Win
23rd May 20247:00 amRNSContract Win
21st May 20247:00 amRNSHalf-year Report
7th May 20247:00 amRNSNotice of half year results
15th Apr 20247:00 amRNSLife Molecular Imaging – Neuraceq Supply Agreement
3rd Apr 20247:00 amRNSImeka Collaboration Agreement
13th Mar 20247:00 amRNSTrading Update
29th Jan 202412:00 pmRNSHolding(s) in Company
25th Jan 20244:00 pmRNSResult of AGM
12th Jan 20249:35 amRNSDirectorate Change
27th Dec 20237:00 amRNSUpdate regarding Nominated Adviser and Broker
15th Dec 20237:00 amRNSChange of Auditor
5th Dec 20237:00 amRNSFinancial Results for year ended 30 September 2023
27th Nov 20237:00 amRNSNotice of Results and Investor Presentation
5th Oct 20237:00 amRNSAppointment of Independent Non-Executive Director
29th Sep 20237:00 amRNSTrading Update
18th Jul 20237:00 amRNSContract Win
14th Jun 20237:00 amRNSContract Win
23rd May 20237:00 amRNSHalf year report
16th May 20237:00 amRNSInvestor Meet Company presentation
10th May 20237:00 amRNSTrading Update
3rd Apr 20238:35 amRNSExtension of Huntington's disease consortium
21st Mar 202312:11 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSContract Win
7th Feb 20237:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.